Determinant spreading: Lessons from animal models and human disease

Immunological Reviews

Volumn 164, Issue , 1998, Pages 209-229

  McCluskey, James ^a   Farris, A Darise ^a   Keech, Catherine L ^a   Purcell, Anthony W ^a   Rischmueller, Maureen ^b   Kinoshita, Gentaro ^c   Reynolds, Pakathip ^c   Gordon, Tom P ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CALRETICULIN; CHAPERONE; HLA ANTIGEN CLASS 2;

ANIMAL MODEL; ANTIBODY RESPONSE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; HUMAN; MOLECULAR MIMICRY; NONHUMAN; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; EPITOPES; HUMANS; MICE; MODELS, IMMUNOLOGICAL; MOLECULAR SEQUENCE DATA; RIBONUCLEOPROTEINS; SJOGREN'S SYNDROME; T-LYMPHOCYTES;

EID: 0031725365     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01222.x     Document Type: Article

References (120)

1. Atkinson MA, Maclaren NK. Islet cell autoantigens in insulin-dependent diabetes. J Clin Invest 1993;92:1608-1616.
2. Steinman L. Multiple sclerosis: presenting an odd autoantigen. Nature 1995;375:739-740.
3. Bernard CC, et al. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J Mol Med 1997;75:77-88.
4. Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 1986;136:1231-1235.
5. Karlsson FA, Burman P, Loof L, Mardh S. Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+,K+-adenosine triphosphatase of the stomach. J Clin Invest 1988;81:475-479.
6. + ATPase (proton pump). Autoimmunity 1992;13:165-172.
7. Hardin JA. The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 1986;29:457-460.
8. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-151.
9. Mattioli M, Reichlin M. Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Arthritis Rheum 1974;17:421-429.
10. Northway JD, Tan EM. Differentiation of antinuclear antibodies giving speckled staining patterns in immunofluorescence. Clin Immunol Immunopathol 1972;1:140-154.
11. Pettersson I, Hinterberger M, Mimori T, Gottleib E, Steitz JA. The structure of mammalian small nuclear ribonucleoproteins: identification of multiple protein components reactive with anti-(U1) ribonucleoprotein and anti-Sm autoantibodies. J Biol Chem 1984;259:5907-5914.
12. Elkon K, et al. Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus. Proc Natl Acad Sci USA 1996;83:7419-7423.
13. Clark G, Reichlin M, Tomasi TB. Characterisation of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 1969;102:117-122.
14. Alspaugh MA, Tan EM. Antibodies to cellular antigens in Sjögren's syndrome. J Clin Invest 1975;55:1067-1073.
15. Ben-Chetrit E, Chan EKL, Sullivan KF, Tan EM. A 52-kD protein is a novel component of the SS-A/Ro particle. J Exp Med 1988;167:1560-1571.
16. Reeves WH, Satoh M, Stajanov L, Wang J. Ku and Ki autoantibodies. In: Peter JB, Shoenfeld Y, eds. Autoantibodies. Amsterdam: Elsevier; 1996. p. 449-455.
17. Ge Q, Wu Y, Trieu EP, Targoff IN. Analysis of the specificity of anti-Pm-Scl autoantibodies. Arthritis Rheum 1994;37:1445-1452.
18. Earnshaw W, Bordwell B, Marino C, Rothfield N. Three human chromosomal autoantigens are recognised by sera from patients with anticentromere antibodies. J Clin Invest 1986;77:426-430.
19. Rattner JB, Rau A, Fritzler MJ, Valencia DW, Yen TJ. CENP-F is a ca. 400 kDa kinetochore protein that exhibits a cell-cycle dependent localisation. Cell Motil Cytoskeleton 1993;26:214-226.
20. Reichlin M. Significance of the Ro antigen system. J Clin Immunol 1986;6:339-348.
21. Hendrick JP, Wolin S, Rinke J, Lerner MR, Steitz JA. Ro small cytoplasmic ribonucleoproteins are a subclass of La ribonucleoproteins: further characterisation of the Ro and La small ribonucleoproteins from uninfected mammalian cells. Mol Cell Biol 1981;12:1138-1149.
22. Gordon TP, Wolfson-Reichlin M, Blalock D, Deveshwar S, Reichlin M. Humoral response in spontaneous and experimental autoimmunity to the ribosomal P proteins. Lupus 1996;5:340-341.
23. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;359:155-157.
24. Brown A, McFarlin DE, Raine CS. Chronic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. Lab Invest 1982;46:171-185.
25. Fritz RB, Chou CH, McFarlin DE. Induction of experimental allergic encephalomyelitis in PL/J and (SJL/JxPL/J)F1 mice by myelin basic protein and its peptides: localisation of a second encephalitogenic determinant. J Immunol 1983;130:191-194.
26. Trotter JL, Clark HB, Collins KG, Wegeschiede CL, Scarpellini JD. Myelin proteolipid protein induces demyelinating disease in mice. J Neurol Sci 1987;79:173-188.
27. McRae BL, Kennedy MK, Tan LJ, Dal Canto MC, Miller SD. Induction of active and adoptive chronic-relapsing experimental autoimmune encephalomyelitis (EAE) using and encephalitogenic epitope of proteolipid protein. J Neuroimmunol 1992;38:229-240.
28. Miller SD, et al. Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases. Immunol Rev 1995;144:224-244.
29. Tuohy VK, Thomas DM. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol 1993;142:1523-1527.
30. Pettinelli CB, McFarlin DE. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt1+2- T lymphocytes. J Immunol 1981;127:1420-1423.
31. Miller SD, et al. Persistent infection with Theiler's virus leads to CNS autoimmunity and epitope spreading. Nat Med 1997;3:1133-1136.
32. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Neville KL, Kim BS. Epitope spreading leads to myelin-specific autoimmune responsed in SJL mice chronically infected with Theiler's virus. J Neuroimmunol 1997;3 (Suppl 1): S62-S65.
33. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med 1995;182:75-85.
34. Lehmann PV, Sercarz EE, Frosthuber T, Dayan CM, Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 1993;14:203-208.
35. Nikcevich KM, et al. IFN-γ-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J Immunol 1997;158:614-621.
36. Miller SD, et al. Blockade of CD28/B7.1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 1995;3:739-745.
37. Rossman MD, Maida BT, Douglas SD. Monocyte-derived macrophage and alveolar macrophage fibronectin production and cathepsin D activity. Cell Immunol 1990;126:268-277.
38. Frosch S, et al. The efficient bovine insulin presentation capacity of bone marrow-derived macrophages activated by granulocyte-macrophage colony-stimulating factor correlates with a high level of intracellular reducing thiols. Eur J Immunol 1993;23:1430-1434.
39. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-1118.
40. Kaufman DM, et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993;366:69-72.
41. Tisch R, Yang X-D, Singer SM, Liblau RS, Fugger L, McDevitt HO. Immune response to glutamic acid decarboxlyase correlates with insulitis in non-obese diabetic mice. Nature 1993;366:72-75.
42. Mitchison MA. The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation. Eur J Immunol 1971;1:18-27.
43. Lake P, Mitchison NA. Regulatory mechanisms in the immune response to cell-surface antigens. Cold Spring Harb Symp Quant Biol 1976;41: 589-595.
44. Rajwesky K, Rottländer E, Peltre G, Müller B. The immune response to a hybrid protein molecule. Specificity of secondary stimulation and of tolerance induction. J Exp Med 1967;126:581-590.
45. Russell SM, Liew FY. T cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin. Nature 1979;280:147-148.
46. Russell SM, Liew FY. Cell cooperation in antibody responses to influenza virus. I. Priming of helper T cells by internal components of the virion. Eur J Immunol 1980;10:791-796.
47. Lou Y-H, McElveen M, Garza K, Tung K. Rapid induction of autoantibodies by endogenous ovarian antigens and activated T cells. J Immunol 1996;156:3535-3540.
48. Lou Y, Tung KSK. T cell peptide of a self-protein elicits autoantibody to the protein antigen. J Immunol 1993;151:5790-5799.
49. McCarron RM, Fallis RJ, McFarlin DE. Alteration in T cell antigen specific and class II restriction during the course of chromic relapsing experimental allergic encephalomyelitis. J Neuroimmunol 1990;29:73-79.
50. Perry, LL, Barzaga-Gilbert E, Trotter JL. T cell sensitisation to proteolipid protein in myelin basic protein-induces experimental allergic encephalomyelitis. J Neuroimmunol 1991;33:7-15.
51. Vincent A, Jacobson L, Shillito P. Response to human acetylcholine receptor alpha-138-199: determinant spreading initiates autoimmunity to self-antigen in rabbits. Immunol Let 1994;39:269-275.
52. Alderuccio F, Toh B-H, Tan P, Gleeson P, van Driel I. An autoimmune disease with multiple molecular targets abrogated by the transgenic expression of a single autoantigen in the thymus. J Exp Med 1993;178:419-426.
53. Elson CJ, Barker RN, Thompson SJ, Williams NA. Immunologically ignorant autoreactive T cells, epitope spreading and repertoire limitation. Immunol Today 1995;16:71-76.
54. Mamula MJ, Fatenejad S, Craft J. B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J Immunol 1994;152:1453-1461.
55. James JA, Gross T, Scofield RH, Harley JB. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B′-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 1995;181:453-461.
56. Bockenstedt LK, Gee RJ, Mamula MJ. Self-peptides in the initiation of lupus autoimmunity. J Immunol 1995;154:3516-3524.
57. James JA, Harley JB. A model of peptide-induced lupus autoimmune B cell epitope spreading is strain specific and is not H-2 restricted in mice. J Immunol 1998;160:502-508.
58. Topfer F, Gordon T, McCluskey J. Intra- and inter-molecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc Natl Acad Sci USA 1995;92:875-879.
59. Scofield RH, Henry WE, Kurien BT, James JA, Harley JB. Immunization with short peptides from the sequence of the systemic lupus erythematosus-associated 60-kDa Ro autoantigen results in anti-Ro ribonucleoprotein autoimmunity. J Immunol 1996;156:4059-4066.
60. Keech CL, Gordon TP, McCluskey J. The immune response to 52-kDa and 60-kDa Ro is linked in experimental autoimmunity. J Immunol 1996;157:3694-3699.
61. Tseng CE, Chan FKL, Miranda E, Gross M, Didonato F, Buyon JP. The 52-kD protein as a target of intermolecular spreading of the immune response to components. Arthritis Rheum 1997;40:936-944.
62. Mamula MJ, Janeway CA. Do B cells drive the diversification of immune responses? Immunol Today 1993;14:151-154.
63. Mamula MJ. Lupus autoimmunity: from peptides to particles. Immunol Rev 1995;144:301-314.
64. Roth R, Gee RJ, Mamula MJ. B lymphocytes as autoantigen-presenting cells in the amplification of autoimmunity. Ann N Y Acad Sci 1997;815:88-104.
65. Lin RH, Mamula MJ, Hardin JA, Janeway CA. Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med 1991;173:1433-1439.
66. Mamula MJ, Lin RH, Janeway CA, Hardin JA. Breaking T cell tolerance with foreign and self co-immunogens: a study of autoimmune B and T cell epitopes of cytochrome c. J Immunol 1992;149:789-795.
67. Fuchs EJ, Matzinger P. B cells turn off virgin, but not memory T cells. Science 1992;258:1156-1159.
68. Gilbert KM, Weigle WO. Tolerogenicity of resting and activated B cells. J Exp Med 1994;179:249-258.
69. Ronchese F, Hausmann B. B lymphocytes in vivo fail to prime naive T cells, but can stimulate antigen-experienced T lymphocytes. J Exp Med 1993;177:679-690.
70. Croft M, Duncan DD, Swain SL. Response of naive antigen-specific CD4+ T cells in vitro: characteristics and antigen-presenting cell requirements. J Exp Med 1992;176:1431-1437.
71. Croft M, Bradley LM, Swain SL. Naive versus memory CD4 T cell response to antigen: memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J Immunol 1994;152:2675-2685.
72. Cassell DJ, Schwartz RH. A quantitative analysis of antigen-presenting cell function: activated B cells stimulate naive CD4 T cells, but are inferior to dendritic cells in providing costimulation. J Exp Med 1994;180:1829-1840.
73. Lanzavecchia A. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu Rev Immunol 1990;8:773-793.
74. Celis E, Zurawski VR, Chang TW. Regulation of T-cell function by antibodies: enhancement of the response of human T-cell clones to hepatitis B surface antigen by antigen-specific monoclonal antibodies. Proc Natl Acad Sci USA 1984;81:6846-6850.
75. Schalke BCG, Klinkert WEF, Wekerle H, Dwyer DS. Enhanced activation of a T cell line specific for acetylcholine receptor (AChR) by using anti-AChR monoclonal antibodies plus receptors. J Immunol 1985;134:3643-3648.
76. Perkins KA, Chain BM. Presentation by peritoneal macrophages: modulation by antibody-antigen complexes. Immunology 1986;58:15-21.
77. Manca F, Fenoglio D, Kunkl A, Cambiaggi C, Sasso M, Celada F. Differential activation of T cell clones stimulated by macrophages exposed to antigen complexed with monoclonal antibodies. J Immunol 1988;140:2893-2898.
78. Thornton BP, Vetvicka V, Ross GD. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J Immunol 1994;152:1727-1737.
79. Boackle SA, Holers VM, Karp DR. CD21 augments antigen presentation in immune individuals. Eur J Immunol 1997;27:122-130.
80. Arvieux J, Yssel H, Colomb MG. Antigen bound C3b and C4b enhance antigen presenting cell function in activation of human T cell clones. Immunology 1988;65:229-235.
81. Dempsey PW, Allison MED, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996;271:348-350.
82. Baughn RE, Jiang A, Abraham R, Ottmers V, Musher DM. Molecular mimicry between an immunodominant amino acid motif on the 47-KDa lipoprotein of Treponema pallidum (TPP47) and multiple repeats of analogous sequences in fibronectin. J Immunol 1996;157:720-731.
83. Dong X, Hamilton KJ, Satoh M, Wang J, Reeves WH. Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen. J Exp Med 1994;179:1243-1252.
84. Sinha AA, Lopez T, McDevitt HO. Autoimmune diseases: the failure of self-tolerance. Science 1990;248:1380-1388.
85. Todd JA, Bell J, McDevitt HO. HLA-DQB gene contributes to susceptibility to insulin-dependent diabetes mellitus. Nature 1987;329:599-604.
86. Tiwari JL, Terasaki PI. Multiple sclerosis. In: Tiwari JL, Terasaki PI, eds. HLA and disease associations. New York: Springer-Verlag; 1985. p. 152-167.
87. Reveille JD. The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome. Curr Opin Rheumatol 1992;4:644-656.
88. Harley JB, et al. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science 1986;232:1145-1147.
89. Rischmueller M, et al. HLA Class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (PSS). Clin Exp Immunol 1998;111:365-371.
90. Tian J, Lehmann PV, Kaufman DL. Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens. J Exp Med 1997;186:2039-2043.
91. Yu M, Johnson JM, Tuohy VK. A predictable and sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J Exp Med 1996;183:1777-1788.
92. Wu B, Deng CS, Goluszko E, Christadoss P. Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis. J Immunol 1997;159:3016-3023.
93. Staines NA, Harper N, Ward FJ, Malmstrom V, Holmdahl R, Bansal S. Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin Exp Immunol 1996;103:368-375.
94. Gleeson PA, Toh B-H, van Driel IR. Organ-specific autoimmunity induced by lymphopenia. Immunol Rev 1996;149:97-125.
95. Neu E, Hemmerich PH, Peter HH, Krawinkel U, Vonmikecz AH. Characteristic epitope recognition pattern of autoantibodies against eukaryotic ribosomal protein L7 in systemic autoimmune diseases. Arthritis Rheum 1997;40:661-667.
96. Tuohy VK, Yu M, Weinstock-Guttman B, Kinkel RP. Diversity and plasticity of self recognition during the development of multiple sclerosis. J Clin Invest 1997;99:1682-1690.
97. Ciubotariu R, et al. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest 1998;101:398-405.
98. Liu ZR, et al. Indirect allorecognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest 1996;98:1150-1157.
99. Satoh M, et al. Autoantibodies that stabilize the molecular interaction of Ku antigen with DNA-dependent protein kinase catalytic subunit. Clin Exp Immunol 1996;105:460-467.
100. Watts C, Lanzavecchia A. Suppressive effect of antibody on processing of T cell epitopes. J Exp Med 1993;178:1459-1463.
101. Simetsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med 1995;181:1957-1963.
102. Wang JS, Dong XW, Stojanov L, Kimpel D, Satoh M, Reeves WH. Human autoantibodies stabilize the quaternary structure of Ku antigen. Arthritis Rheum 1997;40:1344-1353.
103. Fedoseyeva EV, Tam RC, Orr PL, Garovoy MR, Benichou G. Presentation of a self-peptide for in vivo tolerance induction of CD4(+) T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus. J Exp Med 1995;182:1481-1491.
104. Miller JFAP, Morahan G, Allison J. Extra-thymic acquisition of tolerance by T lymphocytes. Cold Spring Harb Symp Quant Biol 1989;54: 807-813.
105. Adelstein S, et al. Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science 1991;251:1223-1225.
106. Goodnow CC. Transgenic mice and analysis of B-cell tolerance. Annu Rev Immunol 1992;10:489-515.
107. Goodnow CC, et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988;334:676-682.
108. Topfer F, Gordon T, McCluskey J. Characterisation of the mouse autoantigen La (SS-B): identification of conserved RNA binding motifs, a putative ATP binding site and reactivity of recombinant protein with poly(U) and human autoantibodies. J Immunol 1993;150:3091-3100.
109. Reynolds P, Gordon TP, Purcell AW, Jackson DC, McCluskey J. Hierarchical self-tolerance to T cell determinants within the ubiquitous nuclear self antigen La (SS-B) permits induction of systemic autoimmunity in normal mice. J Exp Med 1996;184:1-14.
110. Kanost D, McCluskey J. Anergic B cells constitutively present self antigen: enhanced immunoglobulin receptor-mediated presentation of antigenic determinants by B cells is hierarchical. Eur J Immunol 1994;25:1186-1193.
111. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994;179:1317-1330.
112. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs. Nature 1998;392:86-89.
113. Bellone M, et al. Processing of engulfed apoptotic bodies yields T cell epitopes. J Immunol 1997;159:5391-5399.
114. Kinoshita G, Keech CL, Sontheimer RD, Purcell A, McCluskey J, Gordon TP. Spreading of the immune response from 52 kDa Ro and 60 kDa Ro to calreticulin in experimental autoimmunity. Lupus 1998;7:7-11.
115. Knarr G, Gething M-J, Modrow S, Buchner J. BiP binding sequences in antibodies. J Biol Chem 1995;270:27589-27594.
116. Kinoshita G, Purcell AW, Keech CL, Farris AD, McCluskey J, Gordon TP. Immunity to heat shock proteins in experimental anti-Ro autoimmunity. (Submitted).
117. Suto R, Srivastava PK. A mechanism for the specific immunogenicity of heat shock protein chaperoned peptides. Science 1995;269:1585-1588.
118. Gordon T, Mavrangelos C, McCluskey J. Restricted epitope recognition by precipitin-negative anti-La/SS-B-positive sera. Arthritis Rheum 1992;35:663-666.
119. Keech CL, McCluskey J, Gordon TP. Transfection and over-expression of the human 60 kDa Ro/SS-A autoantigen in HEp-2 cells. Clin Immunol Immunopathol 1994;73: 146-151.
120. Arnett FC. Immunogenetics: a tool to analyze autoimmunity. In: Latchman DS, ed. From genetics to gene therapy. Autoimmune diseases: focus on Sjögren's syndrome. London: Bios Scientific Publishers; 1994. p. 147-175.